Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists

This article provides an overview of the efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the treatment of type 2 diabetes mellitus (T2DM). GLP-1 RAs stimulate pancreatic GLP-1 receptors, which increases insulin secretion, delays gastric emptying, and incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Handelsman, Yehuda, Wyne, Kathleen, Cannon, Anthony, Shannon, Michael, Schneider, Doron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408429/
https://www.ncbi.nlm.nih.gov/pubmed/30156445
http://dx.doi.org/10.18553/jmcp.2018.24.9-a.s14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408429/
https://www.ncbi.nlm.nih.gov/pubmed/30156445
http://dx.doi.org/10.18553/jmcp.2018.24.9-a.s14

Ejemplares similares